Virtual Screening Technique Used to Estimate the Mechanism of <i>Adhatoda vasica</i> Nees for the Treatment of Rheumatoid Arthritis Based on Network Pharmacology and Molecular Docking

<div>Molecular docking of active compounds and key targets: (a) kaempferol-3-O-rutinoside to MAPK1; (b) quercetin-3-O-sophoroside to TNF; (c) N-demethyl adhatodine to DHODH; (d) vasicine to IL2; (e) quercetin-3-O-rutinoside to PTGS2; and (f) quercetin-3-O-sophoroside to JAK2.</div>

Evidence-Based Complementary and Alternative Medicine

fig7

Figure 7

Figure 7: Virtual Screening Technique Used to Estimate the Mechanism of <i>Adhatoda vasica</i> Nees for the Treatment of Rheumatoid Arthritis Based on Network Pharmacology and Molecular Docking 

Figure 7 | Virtual Screening Technique Used to Estimate the Mechanism of Adhatoda vasica Nees for the Treatment of Rheumatoid Arthritis Based on Network Pharmacology and Molecular Docking 